TTK HEALTHCARE LIMITED
Latest filings
Next results: Fri, 30 Oct · Financial Results- TTK Healthcare board to approve September quarter results on October 30 · Results
- Routine filing of demat certificate under SEBI Reg 74(5) for Q2 FY27 · Compliance
- Trading Window Closure Ahead of Q2 FY26-27 Results · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates a diversified portfolio across five business segments, generating Rs. 857.28 cr of revenue in FY26. Consumer Products contributed 28.1% of segment revenue (Rs. 241.28 cr, 7.6% EBIT margin); the board has approved the sale of the EVA and Good Home brands in this segment to Wipro Enterprises for Rs. 256 crores plus GST, with these brands accounting for roughly Rs. 148 crores (about 17% of turnover). Protective Devices, at 25.3% of revenue (Rs. 216.51 cr), posted a negative EBIT margin of -4.9% on the loss of USAID institutional business. Foods (17.6%, Rs. 151.10 cr) and Animal Welfare (16.5%, Rs. 141.08 cr) each delivered EBIT margins above 8%. Medical Devices was the smallest segment at 12.5% (Rs. 106.92 cr) but the most profitable with a 21.1% EBIT margin. The company runs 8 manufacturing plants and 41 offices in India, employs 1,259 staff alongside 2,374 workers, and exports to 28 countries; male contraceptives, food products and animal welfare items are the largest product categories.
Scorecard
Measured from the filed financials, judged against its Diversified peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from TTK HEALTHCARE LIMITED's filed financials and exchange disclosures
What does TTK HEALTHCARE LIMITED do?
TTK HEALTHCARE LIMITED is a Diversified company listed on NSE and BSE, trading under the symbol TTKHLTCARE.
Is TTK HEALTHCARE LIMITED profitable?
Yes. Over the trailing twelve months TTK HEALTHCARE LIMITED reported a net profit of ₹74 Cr on revenue of ₹888 Cr.
Does TTK HEALTHCARE LIMITED pay a dividend?
Yes. The dividend yield is 0.98% at the current price. It paid out 22% of its profit as dividend in FY26.
Is TTK HEALTHCARE LIMITED debt-free?
No. It reported borrowings of ₹24 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹2.00 Cr after cash. Debt stands at 0.02× equity. That is lower than 83% of its 13 Diversified peers.
Is TTK HEALTHCARE LIMITED expensive compared with its peers?
On trailing P/E, TTK HEALTHCARE LIMITED ranks 12 of 15 in Diversified — cheaper than 21% of them, against an industry median of 11.5×. This is a position, not a valuation judgement.
How much does the TTK HEALTHCARE LIMITED share price move in a day?
On a typical session TTK HEALTHCARE LIMITED moves 0.94% — that is the median absolute close-to-close move across its last 268 trading days. MarketPing measures each filing's price reaction against it.
When are TTK HEALTHCARE LIMITED's next results?
Financial Results on Fri, 30 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track TTK HEALTHCARE LIMITED's announcements?
Every NSE and BSE filing by TTK HEALTHCARE LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.